Spray Drying

Overcoming formulation challenges is a key step on the path toward commercialization, and spray drying has emerged as an efficacious solution for enhancing the bioavailability of poorly soluble APls. By partnering with an experienced CDMO, drug sponsors can harness extensive capabilities and expertise in process development, scale-up, and manufacturing of spray dried material for preclinical to commercial needs.

Thermo Fisher Scientific has manufacturing capabilities for amorphous solid dispersions to enhance bioavailability of poorly soluble molecules, applicable to a broad range of APIs. Patheon™ Quadrant 2™ predictive modeling will predict the best technology to enable the enhancement of your molecule’s solubility, and the available API manufacturing capabilities, solid state chemistry, and drug product development and commercial supply services enable an integrated offering to solve your challenges and move your product to the next milestone.